What is Zacks Research’s Forecast for Chemours Q2 Earnings?

The Chemours Company (NYSE:CC) – Investment analysts at Zacks Research cut their Q2 2026 earnings estimates for Chemours in a research report issued on Wednesday, March 4th. Zacks Research analyst Team now expects that the specialty chemicals company will post earnings per share of $0.60 for the quarter, down from their previous forecast of $0.69. The consensus estimate for Chemours’ current full-year earnings is $2.03 per share. Zacks Research also issued estimates for Chemours’ Q3 2026 earnings at $0.42 EPS, Q1 2027 earnings at $0.45 EPS, Q2 2027 earnings at $0.53 EPS and FY2028 earnings at $2.50 EPS.

Chemours (NYSE:CC) last released its quarterly earnings results on Thursday, February 19th. The specialty chemicals company reported $0.05 earnings per share for the quarter, topping the consensus estimate of $0.01 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.33 billion. Chemours had a negative net margin of 6.41% and a positive return on equity of 41.75%. The company’s revenue for the quarter was down 2.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.09 EPS.

Several other research firms also recently weighed in on CC. The Goldman Sachs Group raised their target price on Chemours from $14.00 to $18.00 and gave the company a “neutral” rating in a research report on Wednesday, February 25th. Weiss Ratings reiterated a “sell (d)” rating on shares of Chemours in a research report on Wednesday, January 21st. BMO Capital Markets decreased their price objective on Chemours from $20.00 to $19.00 and set an “outperform” rating on the stock in a report on Monday, February 23rd. Mizuho lifted their target price on shares of Chemours from $17.00 to $21.00 and gave the stock an “outperform” rating in a research note on Thursday. Finally, Royal Bank Of Canada reaffirmed an “outperform” rating and set a $18.00 target price on shares of Chemours in a report on Friday, January 16th. Five research analysts have rated the stock with a Buy rating, five have issued a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat, Chemours presently has an average rating of “Hold” and a consensus price target of $18.40.

Chemours Trading Down 1.9%

CC stock opened at $16.44 on Friday. Chemours has a 12-month low of $9.13 and a 12-month high of $21.85. The business’s 50-day moving average is $16.38 and its 200 day moving average is $14.74. The company has a current ratio of 1.78, a quick ratio of 0.85 and a debt-to-equity ratio of 16.33. The stock has a market cap of $2.47 billion, a price-to-earnings ratio of -6.63 and a beta of 1.60.

Institutional Trading of Chemours

A number of hedge funds and other institutional investors have recently modified their holdings of CC. Atlas Capital Advisors Inc. purchased a new position in shares of Chemours during the 4th quarter worth $26,000. MTM Investment Management LLC acquired a new stake in Chemours during the second quarter worth about $27,000. Aster Capital Management DIFC Ltd acquired a new stake in Chemours during the fourth quarter worth about $28,000. Covestor Ltd raised its stake in Chemours by 204.7% during the fourth quarter. Covestor Ltd now owns 2,602 shares of the specialty chemicals company’s stock worth $31,000 after purchasing an additional 1,748 shares during the period. Finally, Eurizon Capital SGR S.p.A. acquired a new position in Chemours in the 4th quarter valued at about $31,000. 76.26% of the stock is owned by institutional investors and hedge funds.

Chemours Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 13th. Shareholders of record on Friday, February 27th will be paid a dividend of $0.0875 per share. The ex-dividend date of this dividend is Friday, February 27th. This represents a $0.35 dividend on an annualized basis and a yield of 2.1%. Chemours’s payout ratio is -14.11%.

Chemours Company Profile

Chemours Company, established in 2015 as a spin-off from E. I. du Pont de Nemours and Company, is a global chemistry organization headquartered in Wilmington, Delaware. Since its formation, Chemours has focused on delivering performance chemicals that help customers lower their carbon footprint, increase energy efficiency and conserve water. The company operates with a commitment to safety, environmental stewardship and innovation.

Chemours’ principal business activities are organized into three core segments.